Byers has been a venture capital investor since 1972. He has been involved with more than fifty new technology-based ventures, over half of which have already become public companies. He birthed the first Life Sciences practice group in the venture capital profession in 1984.
He also led KPCB to become a top-tier venture capital firm in the medical, healthcare, and biotechnology sectors. KPCB has invested in and helped build over 110 Life Sciences companies that have already developed hundreds of products to treat major neglected medical needs for millions of patients.
